Oxcarbazepine

Strengths & Sizes

Note: product and packaging images are not actual size

NDC#31722-023-01
UPC Code331722023016
ImprintV/76

Download Label

Download HDA Sheet

Note: product and packaging images are not actual size

NDC#31722-024-01
UPC Code331722024013
ImprintV/77

Download Label

Download HDA Sheet

Note: product and packaging images are not actual size

NDC#31722-025-01
UPC Code331722025010
ImprintV/78

Download Label

Download HDA Sheet

Indications

Oxcarbazepine tablets are indicated for: • Adults: Monotherapy or adjunctive therapy in the treatment of partial-onset seizures • Pediatrics: - Monotherapy in the treatment of partial-onset seizures in children 4 to 16 years - Adjunctive therapy in the treatment of partial-onset seizures in children 2 to 16 years (1)